Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Sterile Alpha and TIR Motif Containing 1 (SARM1) is an evolutionarily conserved enzyme that functions as an NAD+ nucleosidase. It plays a critical role in programmed axon death (Wallerian degeneration) by depleting axonal NAD+ upon activation. SARM1 is a therapeutic target for neurodegenerative diseases, and its inhibition has shown promise in preventing axon loss after injury or in disease. While it was initially studied for its role in innate immunity, its neuronal function is now considered more prominent. SARM1 is expressed primarily in neurons and also found in macrophages and T cells.
Inhibition of SARM1 NAD+ nucleosidase activity to prevent axonal degeneration.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sterile Alpha and TIR Motif Containing 1 (SARM1).